MD1780G2 - Метод лечения пациентов с циррозом печени - Google Patents
Метод лечения пациентов с циррозом печени Download PDFInfo
- Publication number
- MD1780G2 MD1780G2 MDA20010032A MD20010032A MD1780G2 MD 1780 G2 MD1780 G2 MD 1780G2 MD A20010032 A MDA20010032 A MD A20010032A MD 20010032 A MD20010032 A MD 20010032A MD 1780 G2 MD1780 G2 MD 1780G2
- Authority
- MD
- Moldova
- Prior art keywords
- patients
- hepatic cirrhosis
- treatment
- hepatoprotectors
- losartan
- Prior art date
Links
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 2
- 239000002083 C09CA01 - Losartan Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 abstract 1
- 229960004773 losartan Drugs 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Изобретение относится к медицине, а именно к гепатологии.Сущность изобретения заключается в том, что пациентам с циррозом печени одновременно с введением гепатопротекторов и витаминов дополнительно в течение 27…35 дней назначают losartan по 0,0125…0,025 г один раз в день per os.Ï. ôîðìóëû: 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20010032A MD1780G2 (ru) | 2001-02-02 | 2001-02-02 | Метод лечения пациентов с циррозом печени |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20010032A MD1780G2 (ru) | 2001-02-02 | 2001-02-02 | Метод лечения пациентов с циррозом печени |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1780F1 MD1780F1 (en) | 2001-11-30 |
| MD1780G2 true MD1780G2 (ru) | 2002-05-31 |
Family
ID=19739746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20010032A MD1780G2 (ru) | 2001-02-02 | 2001-02-02 | Метод лечения пациентов с циррозом печени |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1780G2 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4458C1 (ru) * | 2014-06-19 | 2017-08-31 | Мария ДАНУ | Использование препарата Полибиолин при лечении пациентов с циррозом печени |
-
2001
- 2001-02-02 MD MDA20010032A patent/MD1780G2/ru unknown
Non-Patent Citations (2)
| Title |
|---|
| Lebrec D. et al. A randomized controller study of propranolol for prevention of recurrent gastruintestinal bleeding in patients with cirrhosis: a final report. Hepatology, 1984, vol. 4, p. 355-358 * |
| Ohnishi A. et al. Kinetics and dynamics of enalapril in patients with liver cirrhosis. Clinical Pharmacology and Therapeutics, 1989, vol. 45, p. 657-665 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1780F1 (en) | 2001-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135335A0 (en) | Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids | |
| DK0502092T3 (da) | Oralt præparat til behandling af inflammatoriske tarmsygdomme | |
| IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
| DE69831869D1 (de) | Verbesserte verabreichungstechnik für multiple medikamentengaben | |
| MXPA03006217A (es) | Sistema de administracion espaciada de farmacos. | |
| CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
| NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
| ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| MD2549F1 (en) | Method of treatment of the chronic viral hepatitis C | |
| MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
| MXPA04001912A (es) | Aminobenzofenonas novedosas. | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| MXPA01012936A (es) | Composicion farmaceutica que contiene sibutramina y orlistat. | |
| MD1780G2 (ru) | Метод лечения пациентов с циррозом печени | |
| BG105434A (bg) | Сертралинов орален концентрат | |
| SE9800905D0 (sv) | New therapy in glomerulonephritis | |
| GB0018322D0 (en) | Pharmaceutical compositions | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| IL164763A0 (en) | Byperforin derivatives, the use thereof and formulations containing them | |
| TW200501967A (en) | Nemorubicin for use in the preparation of a medicament for liver disease | |
| MD1609F1 (en) | Method of the recidivating chronic aphthous stomatitis treatment | |
| MD1610G2 (ru) | Метод лечения рецидивирующего хронического афтозного стоматита | |
| MD3381G2 (ru) | Метод лечения хронического паротита у детей | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds |